Literature DB >> 2848831

Syncatalytic inactivation of prolyl 4-hydroxylase by synthetic peptides containing the unphysiologic amino acid 5-oxaproline.

V Günzler1, D Brocks, S Henke, R Myllylä, R Geiger, K I Kivirikko.   

Abstract

Peptides containing the unphysiological amino acid 5-oxaproline (Opr) in the sequence R1-Xaa-Opr-Gly-OR2 were found to inactivate prolyl 4-hydroxylase from chick and human origins. Of the substances investigated, compounds with aromatic substituents R1 and R2 were particularly effective when compared with those with an aliphatic group or without a C-terminal blocking group. Both affinity of the individual peptides for the enzyme and partition ratio contributed to the differences in efficiency. Benzylcarbonyl-Phe-Opr-Gly-benzyl ester was the most effective substance tested, its concentration giving 50% inactivation in 1 h being 0.8 microM. Inactivation was only observed in the presence of 2-oxoglutarate and Fe2+. The Opr peptides enhanced the decarboxylation of 2-oxoglutarate by prolyl 4-hydroxylase, the Vmax values obtained with the individual peptides being positively correlated with their inactivating efficiency. Inactivation was prevented by high concentrations of peptide substrate and ascorbate. Lineweaver-Burk kinetics experiments suggested noncompetitive inhibition with respect to peptide substrate and ascorbate. Lysyl hydroxylase was not affected by Opr peptides in concentrations of up to 1.5 mM in either the presence or absence of prolyl 4-hydroxylase. The results suggest that the oxaproline compounds are specific syncatalytic inactivators of prolyl 4-hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

Review 1.  Collagen Prolyl 4-Hydroxylase as a Therapeutic Target.

Authors:  James D Vasta; Ronald T Raines
Journal:  J Med Chem       Date:  2018-07-23       Impact factor: 7.446

2.  Transcriptional regulation of rat liver protein disulphide-isomerase gene by insulin and in diabetes.

Authors:  A Nieto; E Mira; J G Castaño
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

3.  Detection of four oxidation sites in viral prolyl-4-hydroxylase by top-down mass spectrometry.

Authors:  Ying Ge; Brian G Lawhorn; Mariam ElNaggar; Siu Kwan Sze; Tadhg P Begley; Fred W McLafferty
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

4.  Conformational preferences of substrates for human prolyl 4-hydroxylase.

Authors:  Kelly L Gorres; Ram Edupuganti; Grant R Krow; Ronald T Raines
Journal:  Biochemistry       Date:  2008-08-15       Impact factor: 3.162

5.  Inhibition of prolyl 4-hydroxylase by oxalyl amino acid derivatives in vitro, in isolated microsomes and in embryonic chicken tissues.

Authors:  E Baader; G Tschank; K H Baringhaus; H Burghard; V Günzler
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

6.  Prolyl 4 hydroxylase: a critical target in the pathophysiology of diseases.

Authors:  Ravi Kant; Anjana Bali; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2013-04-10       Impact factor: 2.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.